What is a stock summary page? Click here for an overview.
Business Description
Windlas Biotech Ltd
ISIN : INE0H5O01029
Compare
Compare
Traded in other countries / regions
543329.India IPO Date
2021-08-16Description
Windlas Biotech Ltd is a pharmaceutical formulation contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.34 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.18 | |||||
| Interest Coverage | 20.22 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.69 | |||||
| Beneish M-Score | -2.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32 | |||||
| 3-Year EBITDA Growth Rate | 58.4 | |||||
| 3-Year EPS without NRI Growth Rate | 15.1 | |||||
| 3-Year FCF Growth Rate | 170.7 | |||||
| 3-Year Book Growth Rate | 33.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38 | |||||
| 9-Day RSI | 48 | |||||
| 14-Day RSI | 51.4 | |||||
| 3-1 Month Momentum % | 2.42 | |||||
| 6-1 Month Momentum % | 2.78 | |||||
| 12-1 Month Momentum % | 80.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.91 | |||||
| Quick Ratio | 1.61 | |||||
| Cash Ratio | 0.79 | |||||
| Days Inventory | 55.04 | |||||
| Days Sales Outstanding | 75.46 | |||||
| Days Payable | 114.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.54 | |||||
| Dividend Payout Ratio | 0.19 | |||||
| Forward Dividend Yield % | 0.54 | |||||
| 5-Year Yield-on-Cost % | 0.54 | |||||
| 3-Year Average Share Buyback Ratio | 1.5 | |||||
| Shareholder Yield % | 0.26 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.52 | |||||
| Operating Margin % | 9.28 | |||||
| Net Margin % | 8.5 | |||||
| FCF Margin % | 9.81 | |||||
| ROE % | 13.84 | |||||
| ROA % | 9.53 | |||||
| ROIC % | 16.84 | |||||
| 3-Year ROIIC % | 20.93 | |||||
| ROC (Joel Greenblatt) % | 34.44 | |||||
| ROCE % | 18.84 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.92 | |||||
| PE Ratio without NRI | 34.92 | |||||
| Price-to-Owner-Earnings | 22.83 | |||||
| PEG Ratio | 3.68 | |||||
| PS Ratio | 2.96 | |||||
| PB Ratio | 4.55 | |||||
| Price-to-Tangible-Book | 4.48 | |||||
| Price-to-Free-Cash-Flow | 30 | |||||
| Price-to-Operating-Cash-Flow | 19.62 | |||||
| EV-to-EBIT | 22.36 | |||||
| EV-to-EBITDA | 17.56 | |||||
| EV-to-Revenue | 2.61 | |||||
| EV-to-FCF | 29.15 | |||||
| Price-to-GF-Value | 1.89 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.77 | |||||
| Price-to-Graham-Number | 2.61 | |||||
| Price-to-Net-Current-Asset-Value | 8.64 | |||||
| Earnings Yield (Greenblatt) % | 4.47 | |||||
| FCF Yield % | 3.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Windlas Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,263.87 | ||
| EPS (TTM) (₹) | 29.34 | ||
| Beta | 0.39 | ||
| 3-Year Sharpe Ratio | 1.3 | ||
| 3-Year Sortino Ratio | 3.08 | ||
| Volatility % | 48.13 | ||
| 14-Day RSI | 51.4 | ||
| 14-Day ATR (₹) | 65.343272 | ||
| 20-Day SMA (₹) | 1012.9825 | ||
| 12-1 Month Momentum % | 80.13 | ||
| 52-Week Range (₹) | 494.7 - 1197 | ||
| Shares Outstanding (Mil) | 20.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Windlas Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Windlas Biotech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Windlas Biotech Ltd Frequently Asked Questions
What is Windlas Biotech Ltd(BOM:543329)'s stock price today?
The current price of BOM:543329 is ₹999.00. The 52 week high of BOM:543329 is ₹1197.00 and 52 week low is ₹494.70.
When is next earnings date of Windlas Biotech Ltd(BOM:543329)?
The next earnings date of Windlas Biotech Ltd(BOM:543329) is .
Does Windlas Biotech Ltd(BOM:543329) pay dividends? If so, how much?
The Dividend Yield %  of Windlas Biotech Ltd(BOM:543329) is 0.54% (As of Today), Highest Dividend Payout Ratio of Windlas Biotech Ltd(BOM:543329) was 0.19. The lowest was 0.14. And the median was 0.16. The  Forward Dividend Yield % of Windlas Biotech Ltd(BOM:543329) is 0.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers